OVHYAWTZXKGFBM-DWXRJYCRSA-N
C31H29ClF3N9O3 — CID 135192503
Data last refreshed: (MolForge compound catalog, from PubChem)
About OVHYAWTZXKGFBM-DWXRJYCRSA-N
OVHYAWTZXKGFBM-DWXRJYCRSA-N (PubChem CID 135192503) has the molecular formula C31H29ClF3N9O3 and a molecular weight of 668.08 g/mol. Its IUPAC name is (9R,14S)-14-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-6-oxopyrimidin-1-yl]-3-(2-hydroxyethyl)-9-methyl-3,4,7,16-tetrazatricyclo[13.3.1.02,6]nonadeca-1(19),2(6),4,15,17-pentaen-8-one.
Molecular Properties
| Compound Name | OVHYAWTZXKGFBM-DWXRJYCRSA-N |
|---|---|
| PubChem CID | 135192503 |
| Molecular Formula | C31H29ClF3N9O3 |
| Molecular Weight | 668.08 g/mol |
| Exact Mass | 667.20 |
| IUPAC Name | (9R,14S)-14-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-6-oxopyrimidin-1-yl]-3-(2-hydroxyethyl)-9-methyl-3,4,7,16-tetrazatricyclo[13.3.1.02,6]nonadeca-1(19),2(6),4,15,17-pentaen-8-one |
| SMILES | C[C@@H]1CCCC[C@H](n2cnc(-c3cc(Cl)ccc3-n3cc(C(F)(F)F)nn3)cc2=O)c2cc(ccn2)-c2c(cnn2CCO)NC1=O |
| InChI | InChI=1S/C31H29ClF3N9O3/c1-18-4-2-3-5-26(23-12-19(8-9-36-23)29-24(39-30(18)47)15-38-43(29)10-11-45)42-17-37-22(14-28(42)46)21-13-20(32)6-7-25(21)44-16-27(40-41-44)31(33,34)35/h6-9,12-18,26,45H,2-5,10-11H2,1H3,(H,39,47)/t18-,26+/m1/s1 |
| InChIKey | OVHYAWTZXKGFBM-DWXRJYCRSA-N |
| XLogP | 5.15 |
| TPSA | 145.64 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 668.08 |
| LogP ≤ 5 | 5.15 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135192503 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.